Resume

Kanav Jain

Building trustworthy systems for regulated teams. After leaving med school, I watched clinicians lose hours to brittle software and promised to build systems that return time and trust. I lead product teams through regulated environments with clarity, accountability, and user trust at the center.

Print or save as PDF

Opens your browser print dialog for a PDF export.

Focus

Healthcare, finance, and accountable AI systems.

Method

Burden modeling, stoppability, and operational reliability.

Outcome

Reduced friction, safer workflows, and measurable trust.

Summary

Product & systems leadership

A quick scan of focus areas, teams, and the way I work.

Print resume anchor

I design safety rails that keep AI accountable so people stay in control in high-stakes settings.

Product leadership in healthcare and finance. I build tools that keep teams aligned and clear.

Signature teams

Doximity

Scaling clinical communication.

Transcarent

Consumer-directed health experiences.

Andwise

Financial immunization for doctors.

Experience

Selected roles

Leadership roles spanning clinical care, financial systems, and AI safety.

Independent Researcher

The Crumple Zone

2024–present

Documenting playbooks for steerable AI and civic systems, blending neurodiversity-informed design with safety guardrails.

  • Published essays that translate alignment theory into facilitation scripts teams can pilot immediately.
  • Ran reader salons that pressure-tested governance patterns with clinicians, founders, and public sector leaders.
  • Maintained a public log of experiments so learnings stayed reproducible and accountable to participants.

Co-Founder and CEO

Andwise

2022–2024

Co-founded Andwise with Dr. Varun Verma to transform physician financial wellness through personalized guidance, expert access, and education.

  • Raised funding for the Contract Analyzer and shipped it with governance that paired automated reviews with human oversight.
  • Designed advisor routing that kept high-risk recommendations human-reviewed and compliant by default.
  • Built a 60-member medical advisory board with equity ownership to anchor product and policy decisions.
  • Shipped reporting that translated complex plans into plain-language commitments for physicians and their families.

Director of Product, Care Experiences

Transcarent

2021–2022

Directed care experiences across surgery, maternity, fertility, and musculoskeletal (MSK) care, aligning clinicians and benefits teams around completed care plans.

  • Covered multiple divisions (surgery, maternity, fertility, musculoskeletal/MSK) with unified playbooks for clinicians and benefits partners.
  • Created a unified member record so nurses and navigators shared the same facts during live handoffs.
  • Piloted utilization rules that reduced avoidable escalations while keeping high-risk cases clinician-led.
  • Reframed success metrics around completed care plans rather than app opens or call volume.

Director of Product

City of Hope / CancerCompass

2019–2021

Shipped oncology navigation that translated clinical protocols into clear guidance for patients and caregivers.

  • Shipped navigation flows that translated clinical protocols into plain-language steps for patients and families.
  • Built feedback loops with nursing teams to continuously tune triage rules and reduce avoidable escalations.
  • Introduced reliability rituals so content updates and model changes stayed aligned with clinical governance.

Advisor & EIR

Rough Draft & Red Sea

2018–2019

Built coaching rhythms and governance templates for early-stage founders shipping regulated products.

  • Codified facilitation templates that kept investor–founder conversations accountable and non-coercive.
  • Introduced operating reviews that paired qualitative founder health signals with quantitative runway snapshots.
  • Supported portfolio teams shipping regulated products without freezing momentum.

Fellow

GC Venture Fellows

2018–2019

Evaluated early-stage teams with diligence templates surfacing safety, governance, and traction signals together.

  • Built diligence templates that surfaced regulatory and ethical risks alongside traction metrics.
  • Facilitated founder workshops that clarified decision rights and escalation paths pre-investment.
  • Benchmarked portfolio experiments to keep learnings shareable across fellows and partners.

MBA Associate

Red Sea Ventures

Dec 2017–Jan 2019

Supported seed investments and portfolio rituals that kept founder health, mission fit, and growth aligned.

  • Mapped investment memos to post-close milestones so teams and partners stayed aligned on outcomes.
  • Piloted light-touch portfolio reporting that combined qualitative founder signals with quantitative KPIs.
  • Helped spin up sourcing and screening rituals that centered mission fit alongside market potential.

Product Manager

Doximity

2013–2017

Joined Doximity's early team to manage the clinician communication portfolio—including Dialer, mobile messaging, and profiles—to safeguard patient identity at telehealth scale.

  • Launched HIPAA-conscious Doximity Dialer that now powers 100M+ patient–clinician connections and 300K+ clinician users.
  • Expanded the product suite across Dialer, mobile messaging, clinician profiles, and the careers marketplace to keep engagement cohesive.
  • Partnered with compliance and hospital IT to make rollout easy for teams without bespoke integrations.
  • Established reliability playbooks so clinical teams could trust the service during peak demand.

Implementation

Epic

2012–2013

Launched electronic health record (EHR) workflows that reduced alert fatigue while keeping patient safety checks intact.

  • Guided multi-stakeholder go-lives that kept clinicians, IT, and compliance aligned on patient safety outcomes.
  • Mapped policy constraints into decision support that reduced alert fatigue while keeping guardrails intact.
  • Documented playbooks for sustaining reliability after launch so teams could iterate without breaking safety checks.

Research Assistant

Georgia Tech / NASA

2009–2012

Modeled adaptive bio-systems for resilience and signal fidelity.

  • Modeled thermodynamic inhibition in sRNA regulatory networks.
  • Analyzed signal-to-noise regulation in complex adaptive systems.

Education

Academic foundations

Training rooted in biomedical engineering and business leadership.

MBA

NYU Stern School of Business

2019

Finance and technology focus, paired with product leadership in regulated markets and accountable governance.

B.S. Biomedical Engineering (with honors)

Georgia Institute of Technology

2008–2012

Human-centered clinical systems, pairing biomechanics and design research to make care safer and more accessible.

Capabilities

Engagement scope

Partnership areas that show up across audits, delivery, and coaching.

  • Systems product strategy
  • AI safety for care
  • Platform governance
  • Clinical experience design
  • Founder coaching
  • Accessible communication